Found 18 matching trials
CT18 Infant Influenza Priming Study in Vaccine Naive Infants PHASE2 This study evaluates whether priming influenza naive infants, age six to 23...
Show More Location
Vaccine Evaluation Center, BC Children's Hospital
Learn More & Join Trial
Safety and Immunogenicity of a Subunit Trivalent Influenza Vaccine, Northern Hemisphere Formulation 2013/2014, Including MF59C.1 Adjuvant, in Healthy Adults ā„65 Years of Age PHASE2 The present study is designed to confirm the safety and immunogenicity of t...
Show More Location
Antwerp University Centre for the Evaluation of Vaccination
Learn More & Join Trial
FLUADĀ® vs. FluzoneĀ® High-Dose Study PHASE4 The overall aim of the study is to compare safety and immunogenicity of ina...
Show More Location
Centers for Disease Control and Prevention
Learn More & Join Trial
Safety and Immunogenicity of a Surface Antigen, Inactivated, Adjuvanted With MF59C.1, Seasonal Influenza Vaccine, Formulation 2009-2010 PHASE2 This is a trial for annual registration of the updated seasonal influenza v...
Show More Location
Site 2: Ufficio Igiene e SanitĆ Pubblica di Lanciano, ASL Lanciano - Vasto, sede legale Via S. Spaventa, 37
Learn More & Join Trial
A Post-marketing Study to Monitor the Safety of a MF59-adjuvanted Influenza Vaccine Administered in Korean Subjects Aged 65 Years or Older PHASE4 This study will evaluate the safety of an influenza (flu) vaccine in Korean...
Show More Location
KeeTaek Kim internal medicine Clinic
Learn More & Join Trial
Adjuvanted Influenza Vaccine in Stem Cell Transplant PHASE4 Influenza virus is an important cause of morbidity in the transplant popula...
Show More Location
Multiple Locations
Learn More & Join Trial
Immunogenicity of Alternative Annual Influenza Vaccination Strategies in Older Adults in Hong Kong PHASE4 This study allows to evaluate the strength and duration of immune responses...
Show More Location
The University of Hong Kong
Learn More & Join Trial
WU 345: Immune Responses to Adjuvanted and Non-adjuvanted Seasonal Influenza Vaccines in the Lymphoid Tissues. EARLY_PHASE1 Healthy adults (18-49 years of age) with no previous influenza virus vaccin...
Show More Location
Washington University School of Medicine Infectious Disease Clinical Trials Unit.
Learn More & Join Trial
A Study of Modified mRNA Vaccines in Healthy Adults PHASE1 The main goal of this study is to evaluate the safety, reactogenicity, and ...
Show More Learn More & Join Trial
Effects of Aging on Primary and Secondary Vaccine Responses PHASE1 The purpose of this study is to use an existing, unique clinical cohort: th...
Show More Location
Stanford LPCH Vaccine Program
Learn More & Join Trial